Severe Vitamin D Deficiency Is Associated With Increased Expression of Inflammatory Cytokines in Painful Diabetic Peripheral Neuropathy. 2021

Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Background: The exact pathogenic mechanism of the painful diabetic peripheral neuropathy (DPN) is poorly understood. Our study aimed to evaluate the association amongst vitamin D status, inflammatory cytokines, and painful DPN. Methods: A total of 483 patients were divided into three groups, i.e., diabetes without DPN (no-DPN, n = 86), diabetes with painless DPN (painless DPN, n = 176) and diabetes with painful DPN (painful DPN, n = 221) groups. Basic information and laboratory results were collected. The concentrations of vitamin D (25-hydroxyvitamin D), high-sensitivity C-reactive protein, interleukin (IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) were also measured. Results: The prevalence of severe vitamin D deficiency (<10 ng/mL) was more common in the painful DPN group than in the painless DPN and no-DPN groups (25.8,12.5, and 8.1%, respectively, P < 0.01). Cases in the painful DPN group had significantly higher concentrations of IL-6 (P < 0.01) and TNF-α (P < 0.01) than those in the two other groups. The multivariate logistic analysis showed that severe vitamin D deficiency, IL-6, and TNF-α were independent risks for painful DPN after adjusting for confounding factors. Furthermore, the vitamin D status had significantly negative correlations with IL-6 (r = -0.56, P < 0.01) and TNF-α (r = -0.47, P < 0.01) levels. Conclusion: Severe vitamin D deficiency was an independent risk factor for the painful DPN. Severe vitamin D deficiency status may play a role in the painful DPN pathogenesis through elevated IL-6 and TNF-α levels.

UI MeSH Term Description Entries

Related Publications

Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
January 2021, Diabetes/metabolism research and reviews,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
July 2016, Journal of physical therapy science,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
January 2024, Neuropsychiatric disease and treatment,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
January 2019, Diabetic medicine : a journal of the British Diabetic Association,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
March 2012, European journal of internal medicine,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
June 2009, The Journal of clinical endocrinology and metabolism,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
November 2023, Steroids,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
July 2010, AIDS (London, England),
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
January 2018, Asia Pacific journal of clinical nutrition,
Gong Xiaohua, and Luo Dongdong, and Niu Xiaoting, and Chen Shuoping, and Shen Feixia, and Yang Huajun, and Zhou Qi, and Chen Zimiao
December 2023, Cellular and molecular biology (Noisy-le-Grand, France),
Copied contents to your clipboard!